During the last session, Twist Bioscience Corporation (NASDAQ:TWST)’s traded shares were 966,885, with the beta value of the company hitting 0. At the end of the trading day, the stock’s price was $127.64, reflecting an intraday loss of -0.79% or -$1.01. The 52-week high for the TWST share is $214.07, that puts it down -67.71% from that peak though still a striking +79.85% gain since the share price plummeted to a 52-week low of $25.72. The company’s market capitalization is $6.21 Billion, and the average intraday trading volume over the past 10 days was 1.34 Million shares, and the average trade volume was 1.05 Million shares over the past three months.
Twist Bioscience Corporation (TWST) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.6. TWST has a Sell rating from 1 analyst(s) out of 5 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 1 recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.77.
Twist Bioscience Corporation (NASDAQ:TWST): Trading Information
Twist Bioscience Corporation (TWST) registered a -0.79% downside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.21% in intraday trading to $134.6 this Thursday, Apr 01, hitting a weekly high. The stock’s 5-day price performance is 16.34%, and it has moved by 8.58% in 30 days. Based on these gigs, the overall price performance for the year is -9.66%. The short interest in Twist Bioscience Corporation (NASDAQ:TWST) is 3.58 Million shares and it means that shorts have 3.41 day(s) to cover.
The consensus price target of analysts on Wall Street is $145, which implies an increase of 13.6% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $100 and $200 respectively. As a result, TWST is trading at a discount of 56.69% off the target high and -21.65% off the low.
Twist Bioscience Corporation (TWST) projections and forecasts
Statistics show that Twist Bioscience Corporation has underperformed its competitors in share price, compared to the industry in which it operates. Twist Bioscience Corporation (TWST) shares have gone up +55.02% during the last six months, with a year-to-date growth rate less than the industry average at 2% against 8.4%. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 9.4% this quarter and then fall -16.4% in the quarter after that. In the rating firms’ projections, revenue will increase 31.7% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings fell an estimated 0%. While earnings are projected to return 8.9% in 2021, the next five years will return 0% per annum.
Twist Bioscience Corporation (NASDAQ:TWST)’s Biggest Investors
Twist Bioscience Corporation insiders own 9.47% of total outstanding shares while institutional holders control 90.11%, with the float percentage being 99.53%. ARK Investment Management, LLC is the largest shareholder of the company, while 327 institutions own stock in it. As of Dec 30, 2020, the company held over 5.88 Million shares (or 12.08% of all shares), a total value of $830.36 Million in shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The next largest institutional holding, with 3.52 Million shares, is of Vanguard Group, Inc. (The)’s that is approximately 7.24% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $497.82 Million.
Also, the Mutual Funds coming in first place with the largest holdings of Twist Bioscience Corporation (TWST) shares are ARK ETF Tr-ARK Genomic Revolution ETF and ARK ETF Tr-ARK Innovation ETF. Data provided on Feb 27, 2021 indicates that ARK ETF Tr-ARK Genomic Revolution ETF owns about 3,328,142 shares. This amounts to just over 6.84 percent of the company’s overall shares, with a $458.09 Million market value. The same data shows that the other fund manager holds slightly less at 3.01 Million, or about 6.2% of the stock, which is worth about $414.89 Million.